Search

Bank Control Notice, James Long, deadline May 7

The Federal Reserve published a notice under the Change in Bank Control Act that James Long of New Braunfels, Texas has applied to acquire control of First Commercial Financial Corporation by becoming co-trustee of the company's Employee Stock Ownership Plan, which indirectly owns First Commercial Bank, N.A. in Seguin, Texas. The public comment period closes on May 7, 2026, after which the Board will consider the application based on factors enumerated in paragraph 7 of the Act.

Change in Bank Control Notices; Acquisitions of Shares of a Bank or Bank Holding Company

The Federal Reserve System has published a notice seeking public comment on applications under the Change in Bank Control Act. The notice lists one pending acquisition: James Long of New Braunfels, Texas seeks to acquire voting shares of First Commercial Financial Corporation by becoming a co-trustee of its Employee Stock Ownership Plan, which indirectly owns First Commercial Bank, N.A. in Seguin, Texas. Comments must be received by May 7, 2026.

Takeda Pharmaceutical - Implantable Cell Chamber Device, EP4120958A1

The European Patent Office granted Takeda Pharmaceutical Company Limited Patent EP4120958A1 titled 'Implantable Cell Chamber Device and Uses Thereof,' published April 15, 2026. The patent application (filed by inventors LING, Vincent, IMAICHI, Sachiko, PHANEUF, Matthew, LONG, Nathaniel, KASSAB, Rayan, and ROBERTSON, Robbie James) covers technology related to implantable cell chamber devices and their therapeutic applications, with IPC classifications spanning prosthetics (A61F), biomedical materials (A61L), and therapeutic agents (A61P) including gastrointestinal applications. The patent is designated across 31 European member states including Germany, France, the United Kingdom, Italy, Spain, the Netherlands, Belgium, Austria, and Switzerland.